ARS Pharmaceuticals Cash Flow Statement (2020-2026) | SPRY

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-0.02B	-0.02B	0.05B	-0.01B	-0.01B	-0.01B	-0.02B	-0.02B	-0.02B	-0.02B	0.05B	-0.01B	-0.02B	-0.02B	0.05B	-0.04B	-0.05B	-0.05B	0.10B	-0.06B
Depreciation and Depletion (Quarter)	0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Share-based Compensation (Quarter)	0.00B	0.01B	-0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.01B	0.01B	0.01B	0.01B
Gains from Investment Securities (Quarter)	0.01B	0.01B	0.00B	0.00B	0.00B	-0.00B		0.00B	0.00B	0.00B	-0.01B	0.01B	0.01B	0.00B	-0.01B	0.00B	0.01B	0.00B	-0.01B	0.00B
Non-cash Items (Quarter)	0.06B	0.02B	11.39B	0.00B	0.01B	0.03B	0.00B	0.03B	38.18B	0.03B	0.03B	0.08B	0.03B	0.13B	0.07B	0.10B	0.05B	0.05B	0.08B	0.04B
Cash from Operations (Quarter)	-0.01B	-0.02B	0.03B	-0.01B	-0.01B	-0.01B	-0.02B	-0.01B	-0.02B	-0.01B	-0.02B	-0.01B	-0.01B	-0.01B	0.04B	-0.04B	-0.04B	-0.05B	-0.04B	-0.04B
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	0.00B	0.00B	0.00B				0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Amortization of Deferred Charges (Quarter)	0.00B
Depreciation & Amortization (CF) (Quarter)	0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B		0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Change in Working Capital
Change in Receivables (Quarter)														0.00B	0.01B	0.00B	0.01B	0.01B	-0.01B	0.00B
Change in Inventory (Quarter)														0.00B	0.01B	0.01B	0.00B	-0.00B	0.01B	0.00B
Change in Accured Expenses (Quarter)	0.00B	-0.00B	-0.01B	0.00B	-0.00B	0.00B	-0.01B	0.00B	0.00B	0.00B	-0.01B	0.00B	0.00B	0.00B	0.01B	0.00B	0.01B	0.01B	-0.01B	0.01B
Other Working Capital Changes (Quarter)	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B	-0.00B		-0.00B	0.00B	-0.00B			-0.00B	0.00B	0.01B	0.00B	-0.00B	-0.00B	-0.00B	-0.00B
Investing Activities
Capital Expenditures (Quarter)	0.00B	0.00B	-0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	-0.00B	0.00B	0.00B	0.00B	0.01B	-0.01B
Change in Acquisitions & Divestments (Quarter)								0.02B	0.04B	0.06B	0.06B	0.06B	0.07B	0.06B	0.07B	0.06B	0.08B	0.09B	0.07B	0.04B
Cash from Investing Activities (Quarter)	-0.00B	-0.04B	0.04B	-0.00B	-0.00B	-0.00B	-0.00B	-0.11B	0.04B	-0.05B	0.03B	-0.01B	-0.01B	0.02B	-0.10B	0.03B	0.05B	-0.04B	0.02B	0.03B
Financing Activities
Other financing activities (Quarter)												0.00B	0.00B	0.00B		0.00B	0.00B	-0.00B		0.00B
Cash from Financing Activities (Quarter)	0.00B	0.00B	0.05B	-0.00B	-0.00B	-0.00B	0.19B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.07B	0.00B	0.00B	0.10B	0.00B	0.00B
Additional items
Change in Cash (Quarter)	-0.01B	-0.06B	0.12B	-0.01B	-0.01B	-0.01B	0.17B	-0.12B	0.03B	-0.06B	0.01B	-0.01B	-0.02B	0.00B	0.01B	-0.01B	0.01B	0.01B	-0.02B	-0.02B
Free Cash Flow (Quarter)	-0.01B	-0.02B	0.03B	-0.01B	-0.01B	-0.01B	-0.02B	-0.01B	-0.02B	-0.01B	-0.02B	-0.01B	-0.01B	-0.01B	0.04B	-0.04B	-0.05B	-0.04B	-0.04B	-0.04B
Net Cash Flow (Quarter)	-0.01B	-0.06B	0.12B	-0.01B	-0.01B	-0.01B	0.17B	-0.12B	0.03B	-0.06B	0.01B	-0.01B	-0.02B	0.00B	0.01B	-0.01B	0.01B	0.01B	-0.02B	-0.02B

Research Tools

Developers

ARS Pharmaceuticals Cash Flow Statement (2020-2026) | SPRY

Research Tools

Developers

ARS Pharmaceuticals Cash Flow Statement (2020-2026) | SPRY

Create an account

Sign In

Reset Password